Southwick S M, Yehuda R
Clinical Neuroscience Division, VA Administration, Medical Center, West Haven, CT.
Am J Psychother. 1993 Summer;47(3):404-10. doi: 10.1176/appi.psychotherapy.1993.47.3.404.
For patients with PTSD, the effective initiation of additional therapeutic modalities to ongoing individual psychotherapy is challenging. When pharmacologic agents are added, the therapist must carefully consider and monitor the impact of medications on PTSD core symptoms and on adjunctive symptoms such as depression. Further considerations include issues of countertransference, the possible symbolic meaning of medications for both the patient and the therapist, and the appropriate staging of medications. When nonphysician treaters work together with a medical back-up, both parties should frequently communicate with one another in order to avoid unnecessary treatment distortions and disruptions.
对于创伤后应激障碍（PTSD）患者而言，在进行个体心理治疗的同时有效启动其他治疗方式具有挑战性。当添加药物治疗时，治疗师必须仔细考虑并监测药物对PTSD核心症状以及诸如抑郁等附加症状的影响。进一步需要考虑的因素包括反移情问题、药物对患者和治疗师可能具有的象征意义，以及药物的合理应用阶段。当非医生治疗师与医疗支持人员合作时，双方应经常相互沟通，以避免不必要的治疗偏差和干扰。
